We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: 522 Reform Could Lead to More Discussions, Longer Response Time
FDA: 522 Reform Could Lead to More Discussions, Longer Response Time
March 9, 2012
The FDA will consider adding a mandatory pre-522 discussion period before issuing postmarket surveillance orders, officials at an FDA public workshop of the process said Wednesday.